Worth reading
63In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
1500000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise status report for the 20th Stock Acquisition Rights through third-party allotment (with exercise price adjustment clause)
発行・処分する株式数
1,500,000 new shares (number of shares delivered in April 2026)
Existing Shares and Increase
+0.54%Rate of increase
277,417,319 shares278,917,319Shares
0.54% (the exercises from the beginning of the month accounted for 2.54% of the total issued rights, while the exercise ratio subject to the exercise restriction was 0.57%)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
The exercise prices during the target month were ¥27.55, ¥28.50 and ¥26.60. Details of the adjustment clause and the floor price are not disclosed.
Number of Stock Acquisition Rights
Approximately 590,551 rights in total (calculated from the statement that 15,000 rights represented 2.54% of the total issued rights), 471,999 rights unexercised at the end of the previous month, and 456,999 rights unexercised as of the current date
Procedures under the Corporate Code of Conduct
The disclosure states the status of compliance with the exercise deadline under Article 434 of the Listing Regulations.
Most recent equity financing
20th Stock Acquisition Rights issued on 23 December 2025 (with exercise price adjustment clause). The amount is not disclosed.
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status report for the 20th Stock Acquisition Rights through third-party allotment (with exercise price adjustment clause) |
| Number of shares to be issued or disposed of | 1,500,000 new shares (number of shares delivered in April 2026) |
| Dilution Rate | 0.54% (the exercises from the beginning of the month accounted for 2.54% of the total issued rights, while the exercise ratio subject to the exercise restriction was 0.57%) |
| Total number of issued shares | 277,417,319 shares → 278,917,319 shares（Approximately 0.54%） |
| Exercise price | The exercise prices during the target month were ¥27.55, ¥28.50 and ¥26.60. Details of the adjustment clause and the floor price are not disclosed. |
| Number of Stock Acquisition Rights | Approximately 590,551 rights in total (calculated from the statement that 15,000 rights represented 2.54% of the total issued rights), 471,999 rights unexercised at the end of the previous month, and 456,999 rights unexercised as of the current date |
| Procedures under the Corporate Code of Conduct | The disclosure states the status of compliance with the exercise deadline under Article 434 of the Listing Regulations. |
| Most recent equity financing | 20th Stock Acquisition Rights issued on 23 December 2025 (with exercise price adjustment clause). The amount is not disclosed. |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company is reporting the monthly exercise status, but does not state the reason for the exercises.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.